Skip to Content
Merck
  • Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamides.

Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part I: aminoalkoxypyrimidine carboxamides.

Bioorganic & medicinal chemistry letters (2012-05-09)
Wenxin Gu, Tiansheng Wang, Francois Maltais, Brian Ledford, Joseph Kennedy, Yunyi Wei, Christian H Gross, Jonathan Parsons, Leonard Duncan, S J Ryan Arends, Cameron Moody, Emanuele Perola, Jeremy Green, Paul S Charifson
ABSTRACT

A series of 2,6-disubstituted aminoalkoxypyrimidine carboxamides (AAPCs) with potent inhibition of bacterial NAD(+)-dependent DNA ligase was discovered through the use of structure-guided design. Two subsites in the NAD(+)-binding pocket were explored to modulate enzyme inhibitory potency: a hydrophobic selectivity region was explored through a series of 2-alkoxy substituents while the sugar (ribose) binding region of NAD(+) was explored via 6-alkoxy substituents.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DNA Ligase from T4-infected Escherichia coli, buffered aqueous glycerol solution